Applied Genetic Technologies reported $67.85M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alimera Sciences ALIM:US $ 7.86M 2.09M
Applied Genetic Technologies AGTC:US $ 67.85M 4.92M
Avrobio Inc AVRO:US $ 161.66M 27.9M
Biogen BIIB:US $ 2646.6M 897.3M
Bluebird Bio BLUE:US $ 173.15M 66.89M
Celldex Therapeutics CLDX:US $ 25.29M 13.85M
Cti Biopharma CTIC:US $ 96.9M 31.46M
Gilead Sciences GILD:US $ 7000M 2704M
Insmed INSM:US $ 416.08M 99.63M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Life Technologies LIFE:US $ 8.32M 5.99M
Ophthotech OPHT:US $ 141.11M 50.75M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Rigel Pharmaceuticals RIGL:US $ 27.2M 2.52M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M